The Hemoglobin Level as a Prognostic Factor in Patients with Non-Small Cell Lung Cancer Treated with Gemcitabine and cis-Platinum
Objective: Anemia is observed in various malignancies including non- small cell lung cancer /NSCLC/ and is considered to be a poor prognostic factor. The aim of this study is to investigate whether there is a correlation between anemia, other clinic- pathological factors and survival in patients wit...
Main Author: | Deyan N. Davidov |
---|---|
Format: | Article |
Language: | English |
Published: |
Peytchinski Publishing
2012-02-01
|
Series: | Journal of IMAB |
Subjects: | |
Online Access: | http://www.journal-imab-bg.org/issue-2012/book1/JofIMAB2012vol18b1p209-212.pdf |
Similar Items
-
Validation of Pretreatment Prognostic Factors and Prognostic Staging Systems for Small Cell Lung Cancer in a Real-World Data Set
by: Raphael Hagmann, et al.
Published: (2022-05-01) -
Combined systemic immune-inflammatory index and prognostic nutritional index predict outcomes in advanced non-small cell lung cancer patients receiving platinum-doublet chemotherapy
by: Ruiyun Fan, et al.
Published: (2023-04-01) -
Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study
by: Carolina Liguori, et al.
Published: (2023-01-01) -
The effect of choice of platinum on survival and factors affecting survival in metastatic small cell lung cancer: A Single Center Experience
by: Ayşegül Sakin, et al.
Published: (2021-01-01) -
Rechallenge with First-Line Platinum Chemotherapy for Sensitive-Relapsed Small-Cell Lung Cancer
by: Toshihiro Shiozawa, et al.
Published: (2018-09-01)